Avista to back eMolecules
Avista Capital Partners has agreed to invest in eMolecules, an e-procurement platform for high-value chemicals and bioreagents used by pharmaceutical companies in drug discovery.
25 March 2021•3 mins read
Avista Capital Partners has agreed to invest in eMolecules, an e-procurement platform for high-value chemicals and bioreagents used by pharmaceutical companies in drug discovery.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
21 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
21 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
22 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
22 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
22 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
22 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 November 2026 · 3 mins read
